Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD

ClinicalTrials.gov ID: NCT02727881

Public ClinicalTrials.gov record NCT02727881. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OHR-1601: A Phase III Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution, 0.2% Twice Daily in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

Study identification

NCT ID
NCT02727881
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ohr Pharmaceutical Inc.
Industry
Enrollment
230 participants

Conditions and interventions

Interventions

  • Squalamine lactate ophthalmic solution, 0.2% Drug
  • Placebo Ophthalmic solution Drug
  • ranibizumab Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 110 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2016
Primary completion
Nov 30, 2017
Completion
Nov 30, 2017
Last update posted
Apr 26, 2017

2016 – 2017

United States locations

U.S. sites
118
U.S. states
34
U.S. cities
109
Facility City State ZIP Site status
Investigational Site Mobile Alabama 36608
Investigational Site Phoenix Arizona 85014
Investigational Site Phoenix Arizona 85020
Investigational Site Phoenix Arizona 85021
Investigational Site Tucson Arizona 85704
Investigational Site Arcadia California 91007
Investigational Site Beverly Hills California 90211
Investigational Site Campbell California 95008
Investigational Site Fullerton California 92835
Investigational Site Glendale California 91203
Investigational Site Glendora California 91741
Investigational Site La Jolla California 92093
Investigational Site Laguna Hills California 92653
Investigational Site Loma Linda California 92354
Investigational Site Los Angeles California 90017
Investigational Site Oceanside California 92056
Investigational Site Orange California 92868
Investigational Site Palm Desert California 92260
Investigational Site Palo Alto California 94303
Investigational Site Pasadena California 91107
Investigational Site Poway California 92064
Investigational Site Redlands California 92374
Investigational Site Sacramento California 91007
Investigational Site Bridgeport Connecticut 06606
Investigational Site Hamden Connecticut 06518
Investigational Site New London Connecticut 06320
Investigational Site Altamonte Springs Florida 32701
Investigational Site Boynton Beach Florida 33426
Investigational Site Fort Myers Florida 33901
Investigational Site Miami Florida 33136
Investigational Site Miami Florida 33143
Investigational Site Naples Florida 34103
Investigational Site Sarasota Florida 34233
Investigational Site Stuart Florida 34994
Investigational Site Augusta Georgia 30909
Investigational Site ‘Aiea Hawaii 96701
Investigational Site Berwyn Illinois 60402
Investigational Site Bloomington Illinois 61704
Investigational Site Chicago Illinois 60612
Investigational Site Sycamore Illinois 60178
Investigational Site New Albany Indiana 47150
Investigational Site Leawood Kansas 66211
Investigational Site Louisville Kentucky 40202
Investigational Site Paducah Kentucky 42001
Investigational Site Portland Maine 04102
Investigational Site Baltimore Maryland 21209
Investigational Site Baltimore Maryland 21237
Investigational Site Glen Burnie Maryland 21061
Investigational Site Hagerstown Maryland 21740
Investigational Site Pikesville Maryland 21208
Investigational Site Rockville Maryland 20877
Investigational Site Detroit Michigan 48201
Investigational Site Grand Rapids Michigan 49546
Investigational Site Jackson Michigan 49202
Investigational Site Royal Oak Michigan 48073
Investigational Site Southfield Michigan 48304
Investigational Site Traverse City Michigan 49686
Investigational Site Biloxi Mississippi 39532
Investigational Site Chesterfield Missouri 63017
Investigational Site Florissant Missouri 63031
Investigational Site Henderson Nevada 89052
Investigational Site Las Vegas Nevada 89144
Investigational Site Portsmouth New Hampshire 03801
Investigational Site Bloomfield New Jersey 07003
Investigational Site Lawrenceville New Jersey 08648
Investigational Site New Brunswick New Jersey 08901
Investigational Site Northfield New Jersey 08225
Investigational Site Ramsey New Jersey 07446
Investigational Site Teaneck New Jersey 07666
Investigational Site Toms River New Jersey 07083
Investigational Site Brooklyn New York 11223
Investigational Site Great Neck New York 11021
Investigational Site Hauppauge New York 11788
Investigational Site Lynbrook New York 11563
Investigational Site New York New York 10003
Investigational Site New York New York 10032
Investigational Site Rochester New York 14620
Investigational Site Rockville Centre New York 11570
Investigational Site Syracuse New York 13224
Investigational Site Charlotte North Carolina 28210
Investigational Site Concord North Carolina 28025
Investigational Site Cleveland Ohio 44122
Investigational Site Cleveland Ohio 44130
Investigational Site Cleveland Ohio 44195
Investigational Site Toledo Ohio 43615
Investigational Site Youngstown Ohio 44505
Investigational Site Ashland Oregon 97520
Investigational Site Camp Hill Pennsylvania 17011
Investigational Site Kingston Pennsylvania 18704
Investigational Site Lancaster Pennsylvania 17601
Investigational Site Philadelphia Pennsylvania 19104
Investigational Site Philadelphia Pennsylvania 19107
Investigational Site Philadelphia Pennsylvania 19116
Investigational Site Pittsburgh Pennsylvania 15213
Investigational Site Columbia South Carolina 29223
Investigational Site Greenville South Carolina 29605
Investigational Site Mt. Pleasant South Carolina 29464
Investigational Site Rapid City South Dakota 57701
Investigational Site Kingsport Tennessee 37660
Investigational Site Nashville Tennessee 37203
Investigational Site Fort Worth Texas 76107
Investigational Site Grapevine Texas 76051
Investigational Site Harlingen Texas 78550
Investigational Site Houston Texas 77030
Investigational Site Katy Texas 77494
Investigational Site Kingwood Texas 77339
Investigational Site McAllen Texas 78503
Investigational Site Plano Texas 75075
Investigational Site San Antonio Texas 78240
Investigational Site The Woodlands Texas 77384
Investigational Site Salt Lake City Utah 84107
Investigational Site Burlington Vermont 05401
Investigational Site Fairfax Virginia 22031
Investigational Site Warrenton Virginia 20186
Investigational Site Bellevue Washington 98004
Investigational Site Spokane Washington 99204
Investigational Site Morgantown West Virginia 26501
Investigational Site Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02727881, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02727881 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →